Tipo de documento

Artigo

Autor(es)

Afiliação

Palavras-chave

Dose seletiva ou universal para hepatite B
África Subsaariana
Crianças nascidas de mães positivas para o antígeno de superfície da hepatite B (HBsAg)
Ou aqueles cujas mães não foram testadas para infecção pelo vírus da hepatite B (HBV).

Palavras-chave em inglês

Selective or Universal hepatitis B dose
Sub-Saharan Africa
Infants born to hepatitis B surface antigen (HBsAg)-positive mothers
Or those whose mothers were not tested for hepatitis B virus (HBV) infection.

Referência

LEWIS-XIMENEZ, Lia Laura; PELIGANGA, Luis Baião. Selective or universal hepatitis B birth dose in sub-Saharan Africa?. The Lancet, v. 11, p. 1-2, May 2023.

ISSN

1474-547X

Notas

Afifa Ansar and colleagues1 in The Lancet Global Health suggest targeting the hepatitis B birth dose (HepB-BD) in sub-Saharan Africa to only infants born to hepatitis B surface antigen (HBsAg)-positive mothers or those whose mothers were not tested for hepatitis B virus (HBV) infection. This suggestion is based on a systematic review and meta-analysis by the authors in which they did not find a statistical difference for the risk of infant HBV infection when mothers were HBV negative, whether infants received a birth dose (HepB-BD) or a first dose of hepatitis B vaccine only at age 6 weeks. We would like to suggest that these results are not sufficient to revise the current WHO universal Hep-BD vaccine recommendation........